Zurcher Kantonalbank (Zurich Cantonalbank) Corcept Therapeutics Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 18,445 shares of CORT stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,445

Previous 17,259 6.87%

Holding current value

$1.63 Million

Previous $1.97 Million 31.35%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$62.24 - $91.93 $73,816 - $109,028	1,186 Added 6.87%	18,445 $1.35 Million
Q1 2025 May 07, 2025	BUY	$49.85 - $114.22 $42,422 - $97,201	851 Added 5.19%	17,259 $1.97 Million
Q3 2024 Nov 07, 2024	SELL	$29.51 - $46.26 $2,478 - $3,885	-84 Reduced 0.51%	16,408 $759,000
Q2 2024 Jul 29, 2024	SELL	$22.21 - $34.48 $95,458 - $148,195	-4,298 Reduced 20.67%	16,492 $535,000
Q1 2024 Apr 25, 2024	BUY	$21.1 - $27.46 $717 - $933	34 Added 0.16%	20,790 $523,000
Q4 2023 Jan 30, 2024	BUY	$24.82 - $32.88 $174,683 - $231,409	7,038 Added 51.3%	20,756 $674,000
Q1 2023 May 08, 2023	BUY	$19.2 - $24.47 $43,449 - $55,375	2,263 Added 19.76%	13,718 $297,000
Q4 2022 Feb 01, 2023	SELL	$19.95 - $29.96 $30,363 - $45,599	-1,522 Reduced 11.73%	11,455 $232,000
Q2 2022 Aug 09, 2022	SELL	$17.33 - $25.3 $42,267 - $61,706	-2,439 Reduced 15.82%	12,977 $309,000
Q4 2021 Feb 01, 2022	BUY	$17.1 - $23.34 $52,702 - $71,933	3,082 Added 24.99%	15,416 $305,000
Q1 2021 May 03, 2021	SELL	$23.49 - $30.56 $76,295 - $99,258	-3,248 Reduced 20.84%	12,334 $293,000
Q2 2020 Jul 28, 2020	BUY	$11.0 - $18.26 $84,898 - $140,930	7,718 Added 98.14%	15,582 $262,000
Q1 2020 May 06, 2020	BUY	$10.11 - $14.04 $18,693 - $25,959	1,849 Added 30.74%	7,864 $94,000
Q1 2019 Apr 29, 2019	BUY	$10.03 - $15.71 $1,534 - $2,403	153 Added 2.61%	6,015 $71,000
Q3 2018 Nov 09, 2018	BUY	$12.27 - $15.65 $8,331 - $10,626	679 Added 13.1%	5,862 $82,000
Q4 2017 Jan 31, 2018	BUY	$15.77 - $20.72 $36,428 - $47,863	2,310 Added 80.4%	5,183 $94,000
Q3 2017 Nov 08, 2017	BUY	$12.3 - $19.3 $35,337 - $55,448	2,873	2,873 $55,000

Others Institutions Holding CORT

# of Institutions

467

Shares Held

82.8M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $9.44B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Corcept Therapeutics Inc Transaction History